InventionMed S.A. (WSE:INM)
Poland · Delayed Price · Currency is PLN 0.1105
+0.0050 (4.74%)
At close: Aug 14, 2026
InventionMed Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 0.1 | 0 | 0.01 | 3.95 | 5.68 |
Short-Term Investments | 0.05 | 0 | 0 | 0 | 0 | 0 |
Cash & Short-Term Investments | 0.05 | 0.11 | 0.01 | 0.01 | 3.96 | 5.68 |
Cash Growth | 186.51% | 1637.06% | -26.19% | -99.79% | -30.35% | 727.35% |
Accounts Receivable | - | 0.59 | 0.21 | 0.04 | 0.06 | 0.02 |
Other Receivables | 3.08 | 2.07 | 0.59 | 4.21 | 1.88 | 0.47 |
Receivables | 3.08 | 2.66 | 0.8 | 4.25 | 1.95 | 0.49 |
Inventory | - | 0 | 0.04 | - | - | - |
Total Current Assets | 3.12 | 2.77 | 0.84 | 4.26 | 5.9 | 6.17 |
Property, Plant & Equipment | 27.33 | 27.54 | 27.78 | 28.43 | 14.38 | 6.32 |
Long-Term Investments | 9.15 | 9.15 | 9.15 | 10.05 | 10.05 | 31.16 |
Other Intangible Assets | 0.04 | 0.06 | 0.12 | 0.19 | 0.03 | - |
Long-Term Deferred Charges | - | - | - | - | - | 0.01 |
Total Assets | 39.64 | 39.51 | 37.89 | 42.92 | 30.36 | 43.66 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 0.24 | 0.31 | 1.14 | 3.17 | 2.68 |
Accrued Expenses | 13.89 | 0.49 | 0.5 | 0.5 | 10.31 | 6.76 |
Short-Term Debt | - | - | - | - | - | 0.03 |
Current Portion of Long-Term Debt | - | 0 | 0 | 0.93 | 0.01 | - |
Current Income Taxes Payable | - | 0.13 | 0.07 | 0.09 | 0.04 | 0.02 |
Current Unearned Revenue | - | - | - | 0.02 | 0 | - |
Other Current Liabilities | 0.52 | - | - | - | 0 | 0 |
Total Current Liabilities | 14.4 | 0.86 | 0.87 | 2.67 | 13.53 | 9.5 |
Long-Term Debt | 2.82 | 2.68 | 2.49 | 2.32 | 2.3 | - |
Other Long-Term Liabilities | 21.95 | 35.2 | 33 | 31.99 | 6.71 | 4.18 |
Total Liabilities | 39.17 | 38.74 | 36.36 | 36.99 | 22.54 | 13.68 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 20.28 | 20.28 | 20.28 | 20.28 | 20.28 | 20.28 |
Additional Paid-In Capital | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 |
Retained Earnings | -33.65 | -33.34 | -32.59 | -28.18 | -26.3 | -4.14 |
Shareholders' Equity | 0.46 | 0.78 | 1.52 | 5.93 | 7.82 | 29.97 |
Total Liabilities & Equity | 39.64 | 39.51 | 37.89 | 42.92 | 30.36 | 43.66 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.82 | 2.68 | 2.49 | 3.25 | 2.31 | 0.03 |
Net Cash (Debt) | -2.77 | -2.57 | -2.49 | -3.25 | 1.64 | 5.65 |
Net Cash Growth | - | - | - | - | -70.94% | 958.66% |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.02 | 0.01 | 0.03 |
Filing Date Shares Outstanding | 202.79 | 202.79 | 202.79 | 202.79 | 202.79 | 202.79 |
Total Common Shares Outstanding | 202.79 | 202.79 | 202.79 | 202.79 | 202.79 | 202.79 |
Working Capital | -11.28 | 1.91 | -0.03 | 1.58 | -7.63 | -3.34 |
Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.03 | 0.04 | 0.15 |
Tangible Book Value | 0.42 | 0.72 | 1.4 | 5.74 | 7.79 | 29.97 |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.03 | 0.04 | 0.15 |
Construction In Progress | - | - | - | - | 14.38 | 6.32 |